Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

The University of Texas Health Science Center, Houston
Recruiting ID
For more information, see NCT04920097
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).

The investigators will use a randomized control trial, three-group design: (1) APA Group, (2) Sham APA Control, and (3) Usual Care Control. A smartphone application for ecological momentary assessment (EMA) will be used to monitor APA adherence and capture momentary CIN severity and analgesic use.
Virtual Auricular Point Acupressure (APA), In-Person Training, Usual Care
Chemotherapy-induced Neuropathy
Constance Johnson, PhD, MS, RN, Constance H Johnson, PhD, MS, RN

See list of participating sites